A detailed history of Levin Capital Strategies, L.P. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Levin Capital Strategies, L.P. holds 6,942 shares of CRSP stock, worth $339,741. This represents 0.04% of its overall portfolio holdings.

Number of Shares
6,942
Holding current value
$339,741
% of portfolio
0.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$51.17 - $68.18 $355,222 - $473,305
6,942 New
6,942 $374,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.82B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Levin Capital Strategies, L.P. Portfolio

Follow Levin Capital Strategies, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Levin Capital Strategies, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Levin Capital Strategies, L.P. with notifications on news.